Peter Ammann

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2018 · 425 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Unit +6

Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes

Peter Ammann, Marco Maggiorini, Osmund Bertel et al. · Journal of the American College of Cardiology · 2003 · 369 citations

Ill Patients, Cardiogenic Shock, Cardiovascular Disease +11

Elevation of troponin I in sepsis and septic shock

Peter Ammann, Thomas Fehr, Elisabeth I. Minder et al. · Intensive Care Medicine · 2001 · 366 citations

Inflammation, Pathogenesis, Inflammatory Marker +6

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2020 · 243 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Drug-coated Balloons +6

Spontaneous Coronary Artery Dissection

Sebastian Rogowski, Micha T. Maeder, Daniel Weilenmann et al. · Catheterization and Cardiovascular Interventions · 2015 · 241 citations